PLEASE CONTACT THE STUDY COORDINATOR FOR THE TRIAL  OR THE ACADEMIC OFFICE OF CLINICAL TRIALS MAIN LINE AT 713.441.3250
FEATURED CLINICAL TRIALS
COAPT Trial: MitraClip for leaky Heart valve

This trial will evaluate the safety and effectiveness of the MitraClip device for the treatment of moderate-to-severe or severe mitral valve leak, also called functional mitral regurgitation, in patients with heart failure.

Learn how the trial will determine safety and effectiveness >

Clinical Trial:TEAL Study for Breast Cancer
Breast Cancer

This study will evaluate the Pathological Complete Response, which refers to complete disappearance of a tumor from the breast, when trastuzumab emtansine (TDM-1), lapatinib and Abraxane® are combined. This study is for patients with newly diagnosed HER2 positive breast cancer. 

Learn more about assessing the toxicity, safety and efficacy of the drug combination >

Civacir® Polyclonal Immune Globulin (IgG)

The purpose of this study is to test the safety and efficacy of Civacir® to prevent the recurrence of Hepatitis C Virus (HCV) after liver transplant.


Learn more > 

More to Explore